ClassID:

93356

C07C309/29 - CPC Classification

Classification description:

Sulfonic acids; Halides, esters, or anhydrides thereof; Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings

Sub-classes:
Recent Application in this class:
#1
20260092037
2026-04-02

CRYSTALLINE SALT FORMS OF N-((1-(2-(TERT-BUTYLAMINO)-2-OXOETHYL)PIPERIDIN-4-YL) METHYL)-3-CHLORO-5-FLUOROBENZAMIDE AND METHODS OF USE THEREOF

#2
20260085039
2026-03-26

Psilocin crystalline forms

#3
20260003268
2026-01-01

ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR PRODUCING ELECTRONIC DEVICE

#4
20250382299
2025-12-18

SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS

#5
20250129087
2025-04-24

SALT CRYSTALS

#6
20240360101
2024-10-31

PHARMACEUTICAL SALTS OF A CHK-1 INHIBITOR

#7
20240287072
2024-08-29

SOLID STATE FORMS OF LUMATEPERONE SALTS AND PROCESSES FOR PREPARATION OF LUMATEPERONE AND SALTS THEREOF

#8
20240239796
2024-07-18

CRYSTALLINE POLYMORPHS OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR, AND COMPOSITIONS AND METHODS THEREOF

#9
20240239789
2024-07-18

SALTS OF 2-BROMOLYSERGIC ACID DIETHYLAMIDE

#10
20240167922
2024-05-23

TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD

#11
20230167060
2023-06-01

COMPOSITION AND METHODS FOR MODULATING A KINASE CASCADE

#12
20230105412
2023-04-06

5-HT3 RECEPTOR MODULATOR, THE CRYSTALLINE FORM, METHODS OF MAKING, AND USE THEREOF

#13
20220308448
2022-09-29

Photoacid generator for chemically amplified photoresists

#14
20220082938
2022-03-17

ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, RESIST FILM, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE

#15
20220024924
2022-01-27

SOLID STATE FORMS OF LUMATEPERONE SALTS AND PROCESSES FOR PREPARATION OF LUMATEPERONE AND SALTS THEREOF

#16
20210261556
2021-08-26

SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS

#17
20210214305
2021-07-15

COMPOSITION AND METHODS FOR MODULATING A KINASE CASCADE

#18
20210017137
2021-01-21

Salts of an epidermal growth factor receptor kinase inhibitor

#19
20200239460
2020-07-30

TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF

#20
20200181072
2020-06-11

Weakly coloured sulfonic acid

#21
20200039990
2020-02-06

Short-acting benzodiazepine salts and their polymorphic forms

#22
20190389870
2019-12-26

COMPOUND

#23
20190300491
2019-10-03

Salt of quinazoline derivative, preparation method therefor and application thereof

#24
20190263755
2019-08-29

COMPOSITION AND METHODS FOR MODULATING A KINASE CASCADE

#25
20190218172
2019-07-18

Fused tricyclic Γ-amino acid derivative, preparation method therefor, and medical use thereof

#26
20190152925
2019-05-23

Salts of an epidermal growth factor receptor kinase inhibitor

#27
20190010119
2019-01-10

Resist composition and resist patterning process

#28
20180305365
2018-10-25

Pharmaceutical compositions of compound

#29
20180291010
2018-10-11

Fumagillol derivatives and polymorphs thereof

#30
20180282310
2018-10-04

FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE

#31
20180265474
2018-09-20

Polymorphic compounds and uses thereof

#32
20180186803
2018-07-05

Short-acting benzodiazepine salts and their polymorphic forms

#33
20180170875
2018-06-21

Composition and methods for modulating a kinase cascade

#34
20180079715
2018-03-22

METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND ITS PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE

#35
20180039175
2018-02-08

Negative resist composition and resist pattern forming process

#36
20180009787
2018-01-11

Compounds

#37
20180002338
2018-01-04

Short-acting benzodiazepine salts and their polymorphic forms

#38
20170362186
2017-12-21

Salts of a dihydroquinazoline derivative

#39
20170342056
2017-11-30

Compounds

#40
20170298071
2017-10-19

Crystalline solid state form of the benzene sulphonic acid salt of 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide

#41
20170240527
2017-08-24

Acid-addition salt of Trk-inhibiting compound

#42
20170217904
2017-08-03

Salts of an epidermal growth factor receptor kinase inhibitor

#43
20170210912
2017-07-27

Hydrophilic oil repellent and production method of same, surface coating material, coating film, resin composition, oil-water separation filter material, and porous body

#44
20170183337
2017-06-29

TRPV1 antagonists including dihydroxy substituent and uses thereof

#45
20170174720
2017-06-22

CATIONIC STEROIDAL ANTIMICROBIAL SALTS

#46
20170174516
2017-06-22

Titanium ligand-modified black phosphorus and preparation method and use thereof

#47
20170166556
2017-06-15

Fumagillol derivatives and polymorphs thereof

#48
20170114034
2017-04-27

Process for the preparation of vortioxetine salts

#49
20170114026
2017-04-27

Salts of a dihydroquinazoline derivative

#50
20170081286
2017-03-23

2-[[[2-[(Hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof

#51
20170008837
2017-01-12

Lithium styrene sulfonate

#52
20160311850
2016-10-27

CATIONIC STEROIDAL ANTIMICROBIAL SALTS

#53
20160282717
2016-09-29

Resist composition, method for forming resist pattern, photo-reactive quencher and compound

#54
20160251362
2016-09-01

Pyrimidinone compounds as human neutrophil elastase inhibitors

#55
20160251314
2016-09-01

2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof

#56
20160229812
2016-08-11

Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and FLT3 inhibitor

#57
20160222002
2016-08-04

TRPV1 antagonists including dihydroxy substituent and uses thereof

#58
20160176881
2016-06-23

Short-acting benzodiazepine salts and their polymorphic forms

#59
20160168101
2016-06-16

Compounds

#60
20160159735
2016-06-09

Complexes of agomelatine and sulphonic acids, a process for their preparation and pharmaceutical compositions containing them

#61
20160058719
2016-03-03

Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer

#62
20160046623
2016-02-18

Salt of pyrazoloquinoline derivative, and crystal thereof

#63
20160040013
2016-02-11

Colored composition

#64
20160024060
2016-01-28

Benzothiophene derivative

#65
20150376429
2015-12-31

Production process for self-dispersible pigment, self-dispersible pigment, ink, ink cartridge and ink jet recording method

#66
20150338736
2015-11-26

Actinic-ray- or radiation-sensitive resin composition, actinic-ray- or radiation-sensitive film and method of forming pattern

#67
20150307442
2015-10-29

Prodrugs of gaba analogs, compositions and uses thereof

#68
20150168829
2015-06-18

Sulfonium salt, resist composition and resist pattern forming process

#69
20150158867
2015-06-11

AZAADAMANTANE DERIVATIVES AND METHODS OF USE

#70
20150148354
2015-05-28

Crystalline forms of a purine derivative

#71
20150141519
2015-05-21

Agomelatine sulfuric acid complex, and preparation method and application thereof

#72
20150126524
2015-05-07

Salts

#73
20150065584
2015-03-05

Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis

#74
20150045371
2015-02-12

Salts of a dihydroquinazoline derivative

#75
20140364355
2014-12-11

Linear alkylbenzenes from natural oils and methods of producing

#76
20140350007
2014-11-27

Crystalline forms of tricyclic compound acid salt or hydrate thereof, and method for making thereof

#77
20140303194
2014-10-09

Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine

#78
20140274984
2014-09-18

ACID ADDITION SALTS OF 5ALPHA-HYDROXY-6BETA-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3BETA-OL

#79
20140171414
2014-06-19

Pyrimidinone compounds as human neutrophil elastase inhibitors

#80
20140066445
2014-03-06

Composition and methods for modulating a kinase cascade

#81
20140051887
2014-02-20

Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation

#82
20140031386
2014-01-30

Anti-platelet compound addition salt

#83
20130296282
2013-11-07

Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis

#84
20130245261
2013-09-19

Process for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation

#85
20130072504
2013-03-21

Crystalline forms of a purine derivative

#86
20120322810
2012-12-20

NEW SALTS

#87
20120129874
2012-05-24

Salt forms of a xanthine compound

#88
20120122883
2012-05-17

NEW SALTS

#89
20120116088
2012-05-10

2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof

#90
20120077785
2012-03-29

METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS

#91
20120035258
2012-02-09

Methods of using prodrugs of pregabalin

#92
20110171577
2011-07-14

Actinic ray-sensitive or radiation-sensitive resin composition and method of forming pattern with the composition

#93
20100331552
2010-12-30

Acid salt of tolterodine having effective stability for transdermal drug delivery system

#94
20100292501
2010-11-18

PROCESS FOR RECOVERING SULFONIC ACID CATALYST AND NOBLE PRODUCTS FROM ACRYLATE HEAVY ENDS

#95
20100081647
2010-04-01

Short-acting benzodiazepine salts and their polymorphic forms

#96
20090253905
2009-10-08

PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH ALKYL- OR ARYLSULFONATE ANIONS OR ALKYL- OR ARYLCARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT

#97
20090170945
2009-07-02

PREGABALIN SALTS

#98
20090111779
2009-04-30

Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis

#99
20080167336
2008-07-10

Azaadamantane derivatives and methods of use

#100
20070244191
2007-10-18

Strontium salts of sulphonic acids, a process for their preparation and pharmaceutical compositions containing them

#101
20070225518
2007-09-27

5-Aminolevulinic acid salts and their use

#102
20070191481
2007-08-16

Sulphonic acid salt of sibutramine

#103
20070149618
2007-06-28

Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis

#104
20070117043
2007-05-24

Photoacid generators and lithographic resists comprising the same

#105
20060229361
2006-10-12

Prodrugs of GABA analogs, compositions and uses thereof

#106
20050256152
2005-11-17

Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations

#107
20050203122
2005-09-15

Benzenesulfonic acid salts of clopidogrel, methods for preparing same, and pharmaceutical formulations thereof

#108
20050197396
2005-09-08

Crystal of amino acid ester salt and process for producing the same

#109
20050176982
2005-08-11

Method for producing onium salt derivatives, and novel onium salt derivatives

#110
18402996
2024-08-06

Water soluble platinum (II) amino acid schiff base as an antitumor drug

#111
16129285
2020-01-21

Maleamic acid monomer and preparation method and use thereof

#112
15606313
2017-10-31

Compounds